Pharmaceutical ProcessingNovartis CAR-T Cell Therapy Receives FDA Breakthrough DesignationPharmaceutical ProcessingNovartis announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to CTL019, an investigat… Continue reading
ScienceBlog.com (blog)Identical twins; not-so-identical stem cellsScienceBlog.com (blog)Salk scientists and collaborators have shed light on a long-standing question about what leads to variation in stem cells by comparing induced pluripotent stem cell… Continue reading
Technology NetworksBrain Organoid Created from Stem CellsTechnology NetworksScientists at the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg have now succeeded in turning human stem cells derived from skin samples into… Continue reading
Chemical & Engineering News (subscription) |
CRISPR has revolutionised how we approach many diseases – Prof …
Horizon magazine Prof. Toni Cathomen says that using CRISPR-Cas9 to correct eye disorders may be its first in vivo medical application. Image courtesy of Prof. Toni Cathomen. CRISPR pioneer Jennifer Doudna shares her outlook for the …Chemical & Engineering News (subscription) Crispr Therapeutics AG (CRSP) Earns Buy Rating from Analysts at …The Cerbat Gem The CRISPR THERAPTC (CRSP) Given Average Recommendation …Petro Global News 24 |
FOX 13 News, Tampa Bay |
Stem cells could soon treat after effects of stroke
FOX 13 News, Tampa Bay TAMPA (FOX 13) – Three years ago, 54-year-old Robert Kruppa’s life changed. A clot traveling from his legs to his brain caused him to have a massive stroke. “I got up, the left leg gave out, and I landed on the floor and couldn’t get up,” he explained. |
Cincinnati.com |
Elder grad, Wright State athlete considered for stem cell study
Cincinnati.com Reading from a prepared statement, pausing to choke back emotions a few times, the father of the recently injured Wright State University basketball player and Elder High School graduate, Ryan Custer, offered an update on his son’s condition. He’s … |